• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

口腔和口咽鳞状细胞癌的术后放射治疗:治疗对手术切缘阳性患者的影响。

Postoperative radiation therapy for squamous cell carcinomas of the oral cavity and oropharynx: impact of therapy on patients with positive surgical margins.

作者信息

Zelefsky M J, Harrison L B, Fass D E, Armstrong J G, Shah J P, Strong E W

机构信息

Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021.

出版信息

Int J Radiat Oncol Biol Phys. 1993 Jan;25(1):17-21. doi: 10.1016/0360-3016(93)90139-m.

DOI:10.1016/0360-3016(93)90139-m
PMID:8416876
Abstract

PURPOSE

The presence of a positive or close margin after resection of a squamous cancer of the head and neck is associated with a significant risk of local recurrence. To determine the efficacy of postoperative radiation therapy for patients with advanced oral cavity and oropharyngeal cancers with inadequate margins of resection, the present retrospective analysis was undertaken.

METHODS AND MATERIALS

One hundred and two patients were treated with surgery and postoperative radiation therapy for advanced squamous cell carcinomas of the oral cavity and oropharynx. The anatomic subsites treated include oral tongue (n = 29), floor of mouth (n = 22), base of tongue (n = 31) and tonsillar fossa (n = 20). Twenty-five patients (25%) had positive margins, 41 patients (40%) had close margins (< or = 0.5 cm from the surgical margin) and 36 (35%) had negative margins. The median radiation dose was 6000 cGy.

RESULTS

With a median follow-up of 7 years, the actuarial control rate for patients with positive, close and negative margins was 79%, 71%, and 79%, respectively. When postoperative doses of > or = 60 Gy were delivered to patients with positive/close margins (excluding patients with oral tongue lesions), the 7-year actuarial control was 92%. In similar patients receiving < 60 Gy, the actuarial control was 44% (p = 0.0007). Compared to other anatomic subsites, inferior control rates were obtained with oral tongue lesions. For this subsite, the control rates for positive, close, and negative margins were 50%, 62% and 69% respectively.

CONCLUSION

We conclude that excellent local control can be achieved with postoperative radiation therapy, despite the presence of inadequate margins of resection, when doses of > or = 60 Gy are used. Future strategies must be directed at further improving these results in patients with oral tongue lesions.

摘要

目的

头颈部鳞状细胞癌切除术后切缘阳性或接近切缘与局部复发的显著风险相关。为了确定术后放疗对切除切缘不充分的晚期口腔癌和口咽癌患者的疗效,进行了本回顾性分析。

方法和材料

102例患者接受了手术及术后放疗,治疗晚期口腔和口咽鳞状细胞癌。治疗的解剖亚部位包括舌体(n = 29)、口底(n = 22)、舌根(n = 31)和扁桃体窝(n = 20)。25例患者(25%)切缘阳性,41例患者(40%)切缘接近(距手术切缘≤0.5 cm),36例患者(35%)切缘阴性。中位放疗剂量为6000 cGy。

结果

中位随访7年,切缘阳性、接近和阴性患者的精算控制率分别为79%、71%和79%。当对切缘阳性/接近的患者(不包括舌体病变患者)给予术后剂量≥60 Gy时,7年精算控制率为92%。在接受<60 Gy的类似患者中,精算控制率为44%(p = 0.0007)。与其他解剖亚部位相比,舌体病变患者的控制率较低。对于该亚部位,切缘阳性、接近和阴性的控制率分别为50%、62%和69%。

结论

我们得出结论,当使用剂量≥60 Gy时,尽管切除切缘不充分,但术后放疗仍可实现良好的局部控制。未来的策略必须致力于进一步改善舌体病变患者的这些结果。

相似文献

1
Postoperative radiation therapy for squamous cell carcinomas of the oral cavity and oropharynx: impact of therapy on patients with positive surgical margins.口腔和口咽鳞状细胞癌的术后放射治疗:治疗对手术切缘阳性患者的影响。
Int J Radiat Oncol Biol Phys. 1993 Jan;25(1):17-21. doi: 10.1016/0360-3016(93)90139-m.
2
Evaluation of the dose for postoperative radiation therapy of head and neck cancer: first report of a prospective randomized trial.头颈部癌术后放射治疗剂量评估:一项前瞻性随机试验的首次报告
Int J Radiat Oncol Biol Phys. 1993 Apr 30;26(1):3-11. doi: 10.1016/0360-3016(93)90167-t.
3
Long-term treatment results of postoperative radiation therapy for advanced stage oropharyngeal carcinoma.晚期口咽癌术后放射治疗的长期治疗结果
Cancer. 1992 Nov 15;70(10):2388-95. doi: 10.1002/1097-0142(19921115)70:10<2388::aid-cncr2820701003>3.0.co;2-m.
4
The influence of lymph node metastasis in the treatment of squamous cell carcinoma of the oral cavity, oropharynx, larynx, and hypopharynx: N0 versus N+.淋巴结转移对口腔、口咽、喉和下咽鳞状细胞癌治疗的影响:N0与N+的对比
Laryngoscope. 2005 Apr;115(4):629-39. doi: 10.1097/01.mlg.0000161338.54515.b1.
5
Risk factors for local-regional recurrence following preoperative radiation therapy and surgery for head and neck cancer (stage II-IVB).头颈部癌(II-IVB期)术前放疗及手术后局部区域复发的危险因素。
Radiology. 2003 Sep;228(3):789-94. doi: 10.1148/radiol.2283012044.
6
Postoperative brachytherapy alone for T1-2 N0 squamous cell carcinomas of the oral tongue and floor of mouth with close or positive margins.对于切缘接近或阳性的口腔舌部和口底T1-2 N0鳞状细胞癌,单纯术后近距离放射治疗。
Int J Radiat Oncol Biol Phys. 2000 Aug 1;48(1):37-42. doi: 10.1016/s0360-3016(00)00538-1.
7
Postoperative radiotherapy for oral cavity cancers: impact of anatomic subsite on treatment outcome.口腔癌术后放疗:解剖亚部位对治疗结果的影响。
Head Neck. 1990 Nov-Dec;12(6):470-5. doi: 10.1002/hed.2880120604.
8
Treatment of squamous cell carcinoma of the oral cavity, oropharynx and hypopharynx--an analysis of 174 patients in south western Finland.口腔、口咽和下咽鳞状细胞癌的治疗——芬兰西南部174例患者的分析
Acta Oncol. 2003;42(7):756-62. doi: 10.1080/02841860310010907.
9
An analysis of factors influencing the outcome of postoperative irradiation for squamous cell carcinoma of the oral cavity.口腔鳞状细胞癌术后放疗结局的影响因素分析
Int J Radiat Oncol Biol Phys. 1997 Aug 1;39(1):137-48. doi: 10.1016/s0360-3016(97)00152-1.
10
Final Report of a Prospective Randomized Trial to Evaluate the Dose-Response Relationship for Postoperative Radiation Therapy and Pathologic Risk Groups in Patients With Head and Neck Cancer.一项前瞻性随机试验的最终报告,该试验旨在评估头颈部癌患者术后放射治疗的剂量反应关系及病理风险组。
Int J Radiat Oncol Biol Phys. 2017 Aug 1;98(5):1002-1011. doi: 10.1016/j.ijrobp.2017.02.218. Epub 2017 Jul 10.

引用本文的文献

1
A nomogram for predicting overall survival in oral squamous cell carcinoma: a SEER database and external validation study.一种预测口腔鳞状细胞癌总生存期的列线图:一项监测、流行病学和最终结果(SEER)数据库及外部验证研究
Front Oncol. 2025 Mar 17;15:1557459. doi: 10.3389/fonc.2025.1557459. eCollection 2025.
2
Oral Cavity Squamous Cell Carcinoma: Impact of Clear Margin Distance on Locoregional Control in Patients Undergoing Postoperative Radiotherapy.口腔鳞状细胞癌:术后放疗患者切缘距离对局部区域控制的影响。
Technol Cancer Res Treat. 2024 Jan-Dec;23:15330338241258596. doi: 10.1177/15330338241258596.
3
Postoperative SBRT in the treatment of early-stage oropharyngeal and oral cavity cancers with high-risk margins: A dosimetric comparison of volumetric modulated arc therapy with or without non-coplanar arcs and acute toxicity outcomes from the STEREOPOSTOP GORTEC 2017-03 phase 2 trial.
术后立体定向体部放疗治疗具有高危切缘的早期口咽癌和口腔癌:来自STEREOPOSTOP GORTEC 2017 - 03二期试验的容积调强弧形放疗(有无非共面弧形)剂量学比较及急性毒性结果
Clin Transl Radiat Oncol. 2022 Nov 14;38:169-174. doi: 10.1016/j.ctro.2022.11.007. eCollection 2023 Jan.
4
Definitive radiotherapy for squamous cell carcinoma of the oral cavity: a single-institution experience.根治性放疗治疗口腔鳞状细胞癌:单机构经验。
Radiol Oncol. 2021 Nov 19;55(4):467-473. doi: 10.2478/raon-2021-0041.
5
Preservation of swallowing in resected oral cavity squamous cell carcinoma: examining radiation volume effects (PRESERVE): study protocol for a randomized phase II trial.保留口腔切除鳞状细胞癌患者的吞咽功能:研究放疗范围的影响(PRESERVE):一项随机二期临床试验的研究方案。
Radiat Oncol. 2020 Aug 14;15(1):196. doi: 10.1186/s13014-020-01636-x.
6
A multicenter prospective phase II study of postoperative hypofractionated stereotactic body radiotherapy (SBRT) in the treatment of early-stage oropharyngeal and oral cavity cancers with high risk margins: the STEREO POSTOP GORTEC 2017-03 trial.多中心前瞻性 II 期研究:高风险切缘的早期口咽和口腔癌术后分次立体定向放疗(SBRT):STEREO POSTOP GORTEC 2017-03 试验。
BMC Cancer. 2020 Aug 5;20(1):730. doi: 10.1186/s12885-020-07231-3.
7
Survival outcomes after treatment of cancer of the oral cavity (1985-2015).口腔癌治疗后的生存结果(1985-2015 年)。
Oral Oncol. 2019 Mar;90:115-121. doi: 10.1016/j.oraloncology.2019.02.001. Epub 2019 Feb 15.
8
Examining adjuvant radiation dose in head and neck squamous cell carcinoma.检查头颈部鳞状细胞癌的辅助放疗剂量。
Head Neck. 2019 Jul;41(7):2133-2142. doi: 10.1002/hed.25680. Epub 2019 Feb 9.
9
MAGE-A9 in head and neck cancer: Prognostic value and preclinical findings in the context of irradiation.头颈部癌中的MAGE-A9:放疗背景下的预后价值及临床前研究结果
Mol Clin Oncol. 2018 Mar;8(3):513-519. doi: 10.3892/mco.2018.1558. Epub 2018 Jan 19.
10
Cerenkov luminescence imaging (CLI) for image-guided cancer surgery.用于图像引导癌症手术的切伦科夫发光成像(CLI)。
Clin Transl Imaging. 2016;4(5):353-366. doi: 10.1007/s40336-016-0183-x. Epub 2016 May 24.